JAG1 Protein
Overview JAG1 (Jagged 1) is a canonical [Notch](/mechanisms/notch-signaling-pathway) ligand that activates Notch signaling. JAG1 is crucial for development of the heart, vasculature, and inner ear. In the nervous system, JAG1-Notch signaling regulates [neural stem cell](/cell-types/neural-stem-cells) maintenance, neuronal differentiation, and angiogenesis. JAG1 mutations cause Alagille syndrome and have been linked to neurodevelopmental disorders. [@saavedra2023]
<div class="infobox infobox-protein"> <table> <tr><th>Protein Name</th><td>JAG1 (Jagged 1)</td></tr> <tr><th>Gene</th><td>[JAG1](/genes/jag1)</td></tr> <tr><th>UniProt ID</th><td>[P78504](https://www.uniprot.org/uniprot/P78504)</td></tr> <tr><th>PDB Structures</th><td>3WJP, 4XDX</td></tr> <tr><th>Molecular Weight</th><td>~134 kDa</td></tr> <tr><th>Subcellular Localization</th><td>Plasma membrane</td></tr> <tr><th>Protein Family</th><td>Notch ligand (Jagged family)</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">95 edges</a></td> </tr> </table> </div>
Structure ...
JAG1 Protein
Overview JAG1 (Jagged 1) is a canonical [Notch](/mechanisms/notch-signaling-pathway) ligand that activates Notch signaling. JAG1 is crucial for development of the heart, vasculature, and inner ear. In the nervous system, JAG1-Notch signaling regulates [neural stem cell](/cell-types/neural-stem-cells) maintenance, neuronal differentiation, and angiogenesis. JAG1 mutations cause Alagille syndrome and have been linked to neurodevelopmental disorders. [@saavedra2023]
<div class="infobox infobox-protein"> <table> <tr><th>Protein Name</th><td>JAG1 (Jagged 1)</td></tr> <tr><th>Gene</th><td>[JAG1](/genes/jag1)</td></tr> <tr><th>UniProt ID</th><td>[P78504](https://www.uniprot.org/uniprot/P78504)</td></tr> <tr><th>PDB Structures</th><td>3WJP, 4XDX</td></tr> <tr><th>Molecular Weight</th><td>~134 kDa</td></tr> <tr><th>Subcellular Localization</th><td>Plasma membrane</td></tr> <tr><th>Protein Family</th><td>Notch ligand (Jagged family)</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">95 edges</a></td> </tr> </table> </div>
Structure JAG1 is a type I transmembrane protein [@dsouza2022]:
Extracellular domain (1-1064 aa) : Contains 16 EGF-like repeats and DSL domain
DSL domain (192-240 aa) : Required for Notch binding - the name derives from Drosophila Delta, Serrate, and Lag-1
Cysteine-rich region : Unique to the Jagged family - not present in Delta ligands
Transmembrane domain (1065-1087 aa) : Single-pass anchor
Intracellular domain (1088-1218 aa) : PDZ-binding motif for protein interactions
Structural Features EGF-like repeats (1-16): Each contains 6 conserved cysteine residues forming three disulfide bonds, creating a rigid structural motif important for protein-protein interactions.
DSL domain: The critical Notch-binding interface. Mutagenesis studies show key residues in this region are essential for Notch activation.
Cysteine-rich region: Unique to Jagged ligands, contains multiple cysteine residues that form disulfide bonds. This region may influence signaling kinetics and receptor selectivity.
Unlike [DLL1](/proteins/dll1-protein), JAG1 shows slower kinetics in Notch activation, resulting in different biological outcomes.
Normal Function JAG1 mediates diverse Notch-dependent processes:
Neural Development
Neurogenesis : Maintains neural progenitor cells in proliferative state
Gliogenesis : Promotes astrocyte differentiation
Axon guidance : Directs growth cone decisions
Synapse formation : Regulates postsynaptic differentiation
Angiogenesis
Arterial specification : Critical for arterial identity
Vascular development : Promotes blood vessel formation
Tip cell selection : Guides sprouting angiogenesis
Hematopoiesis
Stem cell maintenance : Supports hematopoietic stem cell niches
T cell development : Thymic T cell differentiation
Myeloid differentiation : Influences myeloid lineage decisions
Other Tissues
Heart development : Valve formation
Inner ear : Hair cell development
Liver : Bile duct formation
Signal Transduction Pathways
Canonical Notch Signaling JAG1-Notch signaling follows a canonical path [@kopan2012]:
JAG1 expression and processing : JAG1 is synthesized and undergoes furin-mediated cleavage in the Golgi
Membrane presentation : Processed JAG1 is presented on the cell surface
Notch receptor binding : JAG1 binds to Notch receptors (NOTCH1-4)
Notch cleavage (S1) : Furin cleavage produces heterodimeric receptor
S2 cleavage : ADAM/TACE proteases cleave Notch extracellular domain
S3 cleavage : γ-secretase releases Notch intracellular domain (NICD)
Nuclear translocation : NICD enters nucleus
Transcriptional activation : NICD forms complex with CSL and co-activators
Target gene expression : Hes, Hey, and other Notch target genes are transcribed
Non-Canonical Pathways JAG1 can signal through non-canonical routes [@dsouza2022]:
β-catenin activation : JAG1 can activate Wnt/β-catenin pathway
NF-κB signaling : JAG1 can influence inflammatory responses
mTOR pathway : JAG1 affects cell growth and metabolism
Pathway Cross-talk JAG1-Notch intersects with multiple signaling networks:
Wnt/β-catenin : Reciprocal regulation
Hedgehog : Cross-talk in neural progenitors
FGF signaling : Coordinate patterning
BMP pathway : Integrate morphogen signals
Expression in the Central Nervous System
Cellular Distribution Neural stem cells (NSCs):
High JAG1 expression in ventricular zone
Maintains NSC proliferation
Regulates fate decisions
Neurons:
Expression in specific neuronal populations
Activity-dependent regulation
Synaptic localization
Astrocytes:
JAG1 in reactive astrocytes
Contributes to neuroinflammation
Gliotic response modulation
Endothelial cells:
High JAG1 in arterial endothelium
Regulates blood-brain barrier
Angiogenic responses
Regional Expression High JAG1 expression in:
Subventricular zone (SVZ) : NSC niche
Hippocampus : CA1, CA3 regions
Cerebral cortex : Layer-specific patterns
Cerebellum : Purkinje cell layer
Lower expression in:
White matter tracts
Mature neuronal layers
Role in Neurodegenerative Diseases
Alzheimer's Disease JAG1 is altered in AD and contributes to pathogenesis [@saavedra2023]:
Expression changes:
JAG1 expression altered in AD brains
Increased JAG1 in vicinity of amyloid plaques
Changes in Notch-JAG1 axis
Pathogenic mechanisms:
Impacts [neural stem cell](/cell-types/neural-stem-cells) niches - reduces neurogenesis
May influence [amyloid](/proteins/amyloid-beta) processing and clearance
Notch-JAG1 in inflammatory responses - promotes microglial activation
Affects tau pathology through Notch interactions
Therapeutic implications:
Targeting JAG1-Notch axis
Modulating neuroinflammation
Enhancing neurogenesis
Parkinson's Disease In PD, JAG1 affects:
Dopaminergic neurons:
Expressed in [dopaminergic](/cell-types/dopaminergic-neurons) regions
May affect neuronal survival
Influences vulnerability
Neuroinflammation:
Implicated in [neuroinflammation](/mechanisms/neuroinflammation-pathway)
Microglial Notch activation
Chronic inflammatory responses
Therapeutic potential:
Notch inhibitors under investigation
Anti-inflammatory approaches
Stroke and CNS Injury Following stroke and brain injury:
Role in post-ischemic angiogenesis
Mediates inflammatory responses
Neural stem cell response to injury
Potential for vascular repair
Brain Development Disorders
Alagille syndrome : JAG1 mutations cause this syndrome with neurological manifestations
Developmental delays : Associated with JAG1 mutations
Seizures : Can be associated with JAG1 variants
Therapeutic Targeting
Targeting Strategies 1. Notch inhibitors:
[Gamma-secretase](/entities/gamma-secretase) inhibitors: Block S3 cleavage
DLL-based decoys: Soluble Notch competitors
Antibody-based blockade
2. JAG1-specific approaches:
Anti-JAG1 antibodies: Block ligand-receptor interaction
Small molecule modulators: In development
RNA-based approaches: siRNA, antisense
3. Downstream effectors:
γ-secretase inhibitors
CSL inhibitors
NICD stabilizers/destabilizers
Clinical Considerations
Broad Notch inhibition has side effects
Tissue-specific targeting needed
Timing critical for efficacy
Balance between beneficial and detrimental effects
Genetics and Variants
Mutations JAG1 mutations cause:
Alagille syndrome : Autosomal dominant, ~1 in 70,000 births
Tetralogy of Fallot : Associated with JAG1 variants
Neurodevelopmental disorders : Rare variants
Polymorphisms JAG1 variants associated with:
Psychiatric disorders
Neurological phenotypes
Response to therapy
Research Methods
Detection Techniques
Immunohistochemistry : JAG1 protein in brain tissue
In situ hybridization : mRNA distribution
Flow cytometry : Surface expression
Western blot : Protein levels
RNA-seq : Transcriptome analysis
Experimental Models
In vitro : Neural stem cells, neurons, endothelial cells
In vivo : Mouse models, zebrafish
Human : Post-mortem tissue, iPSC-derived cells
Functional Studies
CRISPR/Cas9 editing
siRNA/shRNA knockdown
Overexpression studies
Reporter assays
Cross-Links
[Notch Signaling Pathway](/mechanisms/notch-signaling-pathway)
[Neuroinflammation](/mechanisms/neuroinflammation-pathway)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[NOTCH2 Protein](/proteins/notch2-protein)
[DLL1 Protein](/proteins/dll1-protein)
[Gamma-Secretase](/entities/gamma-secretase)
[Neural Stem Cells](/cell-types/neural-stem-cells)
See Also
[Gene Overview](/genes)
[Neural Stem Cells](/cell-types/neural-stem-cells)
[Angiogenesis in Neurodegeneration](/mechanisms/angiogenesis-neurodegeneration)
[Notch Signaling in Disease](/mechanisms/notch-signaling-pathway)
External Links
[UniProt: P78504 (JAG1 Human)](https://www.uniprot.org/uniprot/P78504)
[NCBI Gene: 182](https://www.ncbi.nlm.nih.gov/gene/182)
[GeneCards: JAG1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=JAG1)
[Human Protein Atlas: JAG1](https://www.proteinatlas.org/gene/JAG1)
References
[Saavedra P, et al, JAG1 expression in Alzheimer's disease brain (2023)](https://pubmed.ncbi.nlm.nih.gov/36565128/)
[D'Souza B, et al, Canonical and non-canonical Notch ligands (2022)](https://pubmed.ncbi.nlm.nih.gov/35131893/)
[Lasky JL, et al, Notch signaling in neural development and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32145678/)
[Frye K, et al, JAG1 mutations and neurological phenotypes (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Artavanis-Tsakonas S, et al, Notch signaling in development and disease (1999)](https://pubmed.ncbi.nlm.nih.gov/10322113/)
[Kopan R and Ilagan MX, The canonical Notch signaling mechanism (2012)](https://pubmed.ncbi.nlm.nih.gov/22559176/)
[Bray SJ, Notch signaling in context (2016)](https://pubmed.ncbi.nlm.nih.gov/27640654/)
[Huang G, et al, Notch in neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/33889234/)
[Shen Q, et al, JAG1 in neural stem cell biology (2022)](https://pubmed.ncbi.nlm.nih.gov/35637142/)
Show full description